financetom
Business
financetom
/
Business
/
SFIO to probe statutory auditors role in IL&FS crisis
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SFIO to probe statutory auditors role in IL&FS crisis
Oct 4, 2018 11:58 AM

The Serious Fraud Investigation Office (SFIO) will investigate the role of statutory auditors in crisis-hit IL&FS and its subsidiaries amid concerns over financial irregularities, sources privy to the developments told CNBC-TV18.

In a rare move, the government has superseded the board of IL&FS on Monday against the backdrop of debt defaults by some of its group entities that triggered fears of liquidity crunch.

During financial year 2017-18, IL&FS had 169 group companies. Out of them, 24 were direct subsidiaries, 135 indirect subsidiaries, 6 joint ventures and 4 companies were associate companies.

First Published:Oct 4, 2018 8:58 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Iraq's SOMO sells Qaiyarah crude oil to Valero at deep discount, sources say
Iraq's SOMO sells Qaiyarah crude oil to Valero at deep discount, sources say
Sep 20, 2024
SINGAPORE, Sept 20 (Reuters) - Iraq's SOMO has sold 500,000 barrels of Qaiyarah crude to U.S. refiner Valero Energy ( VLO ) , out of the 2 million barrels it offered via a tender on the S&P Platts Market on Close process late on Thursday, trade sources said. Iraq's offer of prompt-loading Qaiyarah crude comes at a time when Asian...
Johnson & Johnson Receives FDA Approval for Non-Small Cell Lung Cancer Treatment
Johnson & Johnson Receives FDA Approval for Non-Small Cell Lung Cancer Treatment
Sep 20, 2024
03:57 AM EDT, 09/20/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said late Thursday the US Food and Drug Administration has approved Rybrevant in combination with chemotherapy for the treatment of adult patients with certain forms of locally advanced or metastatic non-small cell lung cancer. The FDA approval is based on results from a phase 3 study that...
Trump Media shares face potential sell-off as insider selling restrictions lift
Trump Media shares face potential sell-off as insider selling restrictions lift
Sep 20, 2024
(Reuters) - While former U.S. President Donald Trump has said he will not sell his $1.7 billion stake in Trump Media ( DJT ) after restrictions likely expire on Thursday, other insiders could soon cash in their gains. Trump Media & Technology Group ( DJT ) is 57% owned by the Republican presidential candidate who told reporters last Friday that...
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate
Sep 20, 2024
4D Molecular Therapeutics ( FDMT ) stock is trading lower on Thursday after the company released interim follow-up data from the Phase 1/2 PRISM clinical trial and 4FRONT Phase 3 study design. Robust and durable treatment burden reduction was observed in all PRISM populations studied with the planned Phase 3 dose of 3E10 vg/eye of 4D-150. 83% overall reduction in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved